Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias. - Cantilena, Sandra; Gasparoli, Luca; Pal, Deepali; Heidenreich, Olaf; Klusmann, Jan‐Henning; Martens, Joost H. A.; Faille, Alexandre; Warren, Alan J.; Karsa, Mawar; Pandher, Ruby; Somers, Klaartje; Williams, Owen; et al. (Clinical & Translational Medicine, 2022)